1. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner;Gertz;BMC Fam. Pract.,2020
2. Diagnosis and treatment of hereditary transthyretin amyloidosis (hATTR) polyneuropathy: current perspectives on improving patient care;Luigetti;Therapeut. Clin. Risk Manag.,2020
3. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review;Ruberg;J. Am. Coll. Cardiol.,2019
4. Sekijima, Y., November 5, 2001. Hereditary transthyretin amyloidosis. Adam, M.P., Everman, D.B. Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., Amemiya, A., (editors). In GeneReviews. University of Washington, Seattle (WA), 1993–2023 [updated June 17, 2021]. PMID 20301373.